Search

From a top-down perspective, the week has been fine—the S&P 500 and Nasdaq are down less than 1% on the week as of this morning, while broader indexes (small and mid-caps) are up decently. All in all, that keeps the intermediate-term trend pointed nicely higher, with most indexes at least a few percent above their 50-day lines.

This week feels a lot like March. In other words, it’s pretty awful for growth stocks both big and small. The positive momentum from April has seemingly evaporated. There’s no sugar coating it – we’re taking a hit this week. The chatter around higher rates and inflation is getting amplified out there and it’s just a crusher on high valuation/growth stocks.

We’ve had a small pullback in the U.S. stock market averages. It’s a little too early to tell if they might fall further, which could easily happen if the recent increase in hostility that’s coming from North Korea continues to escalate.

This week’s rally was enough to turn the intermediate-term trend up—small caps are still lagging a bit, which isn’t ideal, but every major index is back above its 50-day line, and a couple (S&P 500, NYSE Composite) have nosed out to new highs.

Onto the market, the major indexes had a relatively quiet week ahead of the G20 summit, which is (mostly) taking place over the weekend.

Alexion Pharmaceuticals (ALXN) receives drug approval, Ameriprise (AMP) and XL Group (XL) report third-quarter results, and ratings changes on two of our stocks.

After a vicious wave of rotation and selling among growth stocks and the Nasdaq late last week and early this week, support arrived and the market has been bouncing in recent days.

Throughout 2017, you’ve heard the financial media buzzing about energy sector stocks, enough that you know there’s value there. But timing is everything.

Mike Cintolo shares tips based on how the market actually works...as opposed to how many investors think it works.

As we cruise toward the holiday season, it’s been another good week for the market—as of this morning, the S&P 500 is up nearly 2% while the Nasdaq, S&P 400 Midcap and S&P 600 SmallCap (now up seven weeks in a row!) all are up in the 2.5% to 3% range.

Today’s note includes earnings updates and the podcast.

We discussed a couple of weeks ago how early January is usually volatile, and this year has been no different—in fact, with the headlines out of Washington, D.C., Georgia and more, we’ve seen even more whippy action than normal, with big moves in the indexes and especially among individual stocks and sectors, with 4% moves up and down happening nearly every day.

Fixed income investing has fallen out of favor with the recent performance of bonds, but now’s the time to reconsider how to create income.

It may seem impossible to nail 80% of your options trades, but some basic rules of probability (and a little patience) can lead to major success.

Cannabis stocks have been trending lower all year, but I’m looking at 3 cannabis stock catalysts that could arrive sooner than you think.

Inflation’s bullish impact on precious metals prices has been held back by dollar strength. That could be changing.

Sparked by an inflation data point that showed some signs of cooling, the market surged higher last week. The S&P 500 gained 6%, the Dow rose 4% and the Nasdaq gained a whopping 8.8%.

Small and mid-sized companies are trading at a discount to larger peers, but one sector looks particularly cheap.

With signs of a rebounding oil market, let’s look at two oil pipeline stocks that are well positioned to take advantage of the renewed strength.

2024’s bull market has raised investor sentiment around IPOs, and that’s boosting the prospects of these newly (or almost) public companies.